CHIMERON BIO
Chimeron Bio develops an agent for personalized cancer gene therapy. The company focuses on discovering and developing personalized immunotherapeutics that will revolutionize the treatment of cancer. The company was founded in 2015 and is headquartered in Philadelphia, Pennsylvania.
CHIMERON BIO
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.chimeronbio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.15 M USD
Technology used in webpage:
Google Apps For Business GoDaddy DNS Google Google Cloud Google Cloud South Carolina
Similar Organizations
Accuronix Therapeutics
Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Allozyne
Allozyne develops technologies that improve the efficacy, safety, dosing, and other characteristics of protein-based therapeutics.
AmideBio
AmideBio develops and commercializes peptide research reagents and clinical products for clinical and therapeutic marketplaces.
Annovation BioPharma
Annovation BioPharma develops pharmaceutical products for anesthesia, sedation and sleep.
Biochip Labs
Biochip Labs provides blood disorder testing for conditions like sickle cell disease and thalassemia.
Biotesserae Camunity
Biotesserae Camunity develops a nanobody-based platform designed for canine cancer treatments.
Brain Neurotherapy Bio
Brain Neurotherapy Bio focuses on the clinical translation and development of neurotrophic factor gene therapy.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Camallergy
Camallergy develops and provides new treatments for common food allergies.
CASPR Biotech
CASPR Biotech develops a CRISPR-based platform for molecular detection.
Cerebrum Health Centers
Cerebrum Health Centers is an organization dedicated to renewing hope and changing lives through brain-based therapy.
Entrinsic Bioscience
Entrinsic Bioscience leverages gold standard science and game-changing amino acid technology.
Enzium
Enzium develops fluorescent based reagents for selective protease.
Exegenesis Bio
Exegenesis Bio is a Gene therapy start-up.
GeneBiology
GeneBiology develops a patented new drugs for serious diseases using the 505(b)(2) regulatory pathway.
Invictus Oncology
Invictus Oncology develops therapeutics for cancer treatment.
Kaio Therapy
Kaio Therapy develops a novel hyperthermia system that delivers controlled heat at the cellular level within a tumor.
Lutris Pharma
Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.
Maryland Proton Treatment Center
MPTC provides patient care by offering a system of image-guided proton therapy and intensity-modulated proton therapy.
Mavalon Therapeutics
Mavalon is developing drugs to stop the progression of Parkinson's disease.
Nimbus Apollo
Nimbus Apollo, Inc. research and develops drugs that treats non-alcoholic steatohepatitis.
Oricula Therapeutics
Oricula Therapeutics develops and commercializes drugs to prevent hearing loss.
PrIME Biologics
PrIME Biologics Pte Limited develops a disposable procedure
Rafael Holdings
Rafael Holdings is a company focused on the development of novel cancer therapies.
Recludix Pharma
Recludix pharma is a developing platform to treat cancer patients.
Revitope Oncology
Revitope is developing a novel approach to cancer immunotherapy.
Sino Biological
Sino Biological is a specialist provider of protein, antibody and gene products.
Symbiotic Health
Symbiotic Health develops transformative microbiome-based therapies to address critical public health challenges.
ThermaGenix
ThermaGenix is a polymerase chain reaction improvement company.
Thrive Agrobiotics
Thrive Agrobiotics engages in research and development by utilizing gut cell therapy platform.
Tiltan Pharma
One of the major advances in cancer research over the past decade has been the realization that tumor growth is dependent on the tumor's
Virogin Biotech
Virogin Biotech is an antineoplastic drug developer.
Western Oncolytics
Western Oncolytics develops novel therapies for cancer that show promise and demonstrate their value to patients.
Zebra Biologics
Zebra Biologics develops bio superior agonist and antagonist antibody therapeutics for many diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.chimeronbio.com
- Host name: 68.233.243.35.bc.googleusercontent.com
- IP address: 35.243.233.68
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Chimeron Bio"
Chimeron Bio - Crunchbase Company Profile & Funding
Chimeron Bio develops an agent for personalized cancer gene therapy. The company focuses on discovering and developing personalized immunotherapeutics that will revolutionize the treatment of cancer. The …See details»
Chimeron Bio Company Profile 2024: Valuation, Funding
Chimeron Bio has 14 total employees. What industry is Chimeron Bio in? Chimeron Bio’s primary industry is Drug Discovery. Is Chimeron Bio a private or public company? Chimeron Bio is a …See details»
Chimeron Bio Enters Into Manufacturing Agreement With …
Apr 12, 2022 Philadelphia, PA and College Station, TX – April 12, 2022 ‒ Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics designed on its …See details»
Our Mission - Chimeron Bio | Redefining Cancer Therapeutics
“Our research is imperative for medical science moving into the future – and we’re uniquely equipped to advance this field and address unmet needs for patients around the world.” Kevin …See details»
Chimeron Bio - LinkedIn
Chimeron Bio is an early-stage biotech company focused on breakthrough treatments of cancer. Chimeron’s patented Multiplex nanoparticle and self-amplifying mRNA technology enables delivery of ...See details»
Chimeron Bio Enters Into Manufacturing Agreement With ... - Fujifilm
Apr 12, 2022 Philadelphia, Penn. and College Station, Tex. – Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics designed on its …See details»
Leadership Team - Chimeron Bio | Redefining Cancer …
LEADERSHIP TEAM Seasoned scientific leaders with deep pharma and R&D expertise CEO & Board Member Kevin Heyeck Chief Financial Officer Monica Coleman Board Member Antonin de Fougerolles, Ph.D. Chairman of the …See details»
Chimeron Bio Enters Into Manufacturing Agreement …
Apr 12, 2022 FUJIFILM Diosynth Biotechnologies, a subsidiary of FUJIFILM Corporation, is a world-leading contract development and manufacturing organization (CDMO) with experience in the development and ...See details»
Chimeron Bio - Craft
Chimeron Bio is a company focused on RNA (ribonucleic acid) therapeutics. It offers the ChaESAR platform that leverages chimera encased self-amplifying RNA (saRNA) to develop …See details»
Chimeron Bio - Updates, News, Events, Signals & Triggers
Chimeron Bio is focused on developing innovative vaccine solutions, specifically peptide VLP-based vaccines designed to deliver immunogenic antigens and induce protective immune …See details»
Chimeron Bio Enters Into Manufacturing Agreement With …
Apr 12, 2022 About Chimeron Bio . ... Biotechnologies, a subsidiary of FUJIFILM Corporation, is a world-leading contract development and manufacturing organization (CDMO) with …See details»
Chimeron Bio Enters Into Manufacturing Agreement With …
Apr 12, 2022 Philadelphia, PA and College Station, TX – Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics designed on its …See details»
Amplifying the efficacy of RNA medicines - Nature
Chimeron Bio aims to transform RNA therapy with its novel nanoparticle technology by developing new vaccines and therapies based on self-amplifying RNA for the treatment of infectious …See details»
Chimeron Bio Enters Into Manufacturing Agreement With
Apr 12, 2022 FUJIFILM Diosynth Biotechnologies, a subsidiary of FUJIFILM Corporation, is a world-leading contract development and manufacturing organization (CDMO) with experience …See details»
Chimeron Bio Appoints Antonin de Fougerolles to its Board of …
Dec 15, 2022 Philadelphia, PA – Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics designed on its proprietary ChaESAR™ RNA …See details»
Chimeron Bio Enters Into an Agreement With the NIAID, a Federal …
Mar 21, 2022 Chimeron Bio Enters Into an Agreement With the NIAID, a Federal Agency, for Pre-clinical Assessment of Its Self-Amplifying COVID-19 Vaccine. March 21, 2022 01:20 PM …See details»
Chimeron Bio Welcomes Kevin Heyeck as New CEO
Dec 13, 2022 Philadelphia, PA – Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics designed on its proprietary ChaESAR™ RNA …See details»
News & Events - Chimeron Bio | Redefining Cancer Therapeutics
Apr 16, 2024 Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development. Press Releases. Apr 16, 2024 Chimeron Bio receives NIH (NCI) …See details»
Pipeline - Chimeron Bio | Redefining Cancer Therapeutics
We’re applying our scientific expertise and proprietary technology to create and deliver next generation RNA therapeutics. Our development pipeline is focused on three innovative …See details»